New Approach Methodologies (Nams) to Assess Thyroid Endocrine Disruption-Mediated Cardiovascular Outcomes: an Example Focused on the Emerging Contaminant Octylmethoxycinnamate
AuthID
P-01B-7ST
P-01B-7ST